MedPath

A phase 2 study of proton therapy for inoperable stage I non-small cell lung cancer

Phase 2
Conditions
Stage I non-small cell lung cancer
Registration Number
JPRN-UMIN000045504
Lead Sponsor
agoya City University West Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

1) Pregnancy 2) Synchronous or metachronous cancer 3) Active infectious disease 4) Other severe comorbidities 5) Severe psychological disorder 6) Apparent interstitial pneumonitis or pulmonary fibrosis detectable by chest X-ray radiography 7) Judged as inappropriate to participation by investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of grade 3 and higher radiation pneumonitis within 180 days after the start of irradiation
Secondary Outcome Measures
NameTimeMethod
ocal control rate, overall survival period, progression-free survival period, event-free survival period, local progression-free survival period, patterns of failure, adverse event, QO
© Copyright 2025. All Rights Reserved by MedPath